{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:18:31Z","timestamp":1783333111704,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08382"],"award-info":[{"award-number":["23K08382"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003790","name":"Hiroshima University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003790","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth"],"DOI":"10.1007\/s00540-026-03822-9","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:56:24Z","timestamp":1783331784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary myotubes as an alternative to the calcium induced calcium release test in diagnosing malignant hyperthermia susceptibility"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4771-9867","authenticated-orcid":false,"given":"Sachiko","family":"Otsuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Mukaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1375-5344","authenticated-orcid":false,"given":"Hirotsugu","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenshiro","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Sumii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimichi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke T.","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo M.","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"3822_CR1","first-page":"355","volume":"10","author":"D Schneiderbanger","year":"2014","unstructured":"Schneiderbanger D, Johannsen S, Roewer N, Schuster F. Management of malignant hyperthermia: diagnosis and treatment. Ther Clin Risk Manag. 2014;10:355\u201362.","journal-title":"Ther Clin Risk Manag"},{"key":"3822_CR2","doi-asserted-by":"crossref","unstructured":"Carpenter D, Ringrose C, Leo V, Morris A, Robinson RL, Halsall PJ, Hopkins PM, Shaw MA. The role of CACNA1S inpredisposition to malignant hyperthermia. BMC Med Genet. 2009;10:104","DOI":"10.1186\/1471-2350-10-104"},{"key":"3822_CR3","doi-asserted-by":"crossref","unstructured":"Toyota Y, Kondo T, Shorin D, Sumii A, Kido K, Watanabe T, Otsuki S, Kanzaki R, Miyoshi H, Yasuda T, Horikawa YT,Mukaida K, Tsutsumi YM. Rapid Dantrolene Administration with Body Temperature Monitoring Is Associated withDecreased Mortality in Japanese Malignant Hyperthermia Events. Biomed Res Int. 2023;2023:8340209.","DOI":"10.1155\/2023\/8340209"},{"key":"3822_CR4","doi-asserted-by":"crossref","unstructured":"Ibarra M CA, Wu S, Murayama K, Minami N, Ichihara Y, Kikuchi H, Noguchi S, Hayashi YK, Ochiai R, Nishino I.Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region bydirect sequencing. Anesthesiology 2006;104:1146\u201354.","DOI":"10.1097\/00000542-200606000-00008"},{"key":"3822_CR5","doi-asserted-by":"crossref","unstructured":"Girard T, Treves S, Voronkov E, Siegemund M, Urwyler A. Molecular genetic testing for malignant hyperthermia susceptibility. Anesthesiology. 2004;100:1076\u201380.","DOI":"10.1097\/00000542-200405000-00008"},{"key":"3822_CR6","doi-asserted-by":"crossref","unstructured":"Ording H, Brancadoro V, Cozzolino S, Ellis FR, Glauber V, Gonano EF, Halsall PJ, Hartung E, Heff ron JJ, Heytens L,Kozak-Ribbens G, Kress H, Krivosic-Horber R, Lehmann-Horn F, Mortier W, Nivoche Y, Ranklev-Twetman E, SigurdssonS, Snoeck M, Stieglitz P, Tegazzin V, Urwyler A, Wappler F. In vitro contracture test for diagnosis of malignanthyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MHand unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand.1997;41:955\u201366.","DOI":"10.1111\/j.1399-6576.1997.tb04820.x"},{"key":"3822_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00000542-199803000-00006","volume":"88","author":"GC Allen","year":"1998","unstructured":"Allen GC, Larach MG, Kunselman AR. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. Anesthesiology. 1998;88:579\u201388.","journal-title":"Anesthesiology"},{"key":"3822_CR8","doi-asserted-by":"crossref","unstructured":"Kawana Y, Iino M, Horiuti K, Matsumura N, Ohta T, Matsui K, Endo M. Acceleration in calcium-induced calcium release in the biopsied muscle fibers from patients with malignant hyperthermia. Biomed Res. 1992;13:287\u201397.","DOI":"10.2220\/biomedres.13.287"},{"key":"3822_CR9","doi-asserted-by":"crossref","unstructured":"Hopkins PM, R\u00fcff ert H, Snoeck MM, Girard T, Glahn KP, Ellis FR, M\u00fcller CR, Urwyler A; European MalignantHyperthermia Group. European Malignant Hyperthermia Group guidelines for investigation of malignanthyperthermia susceptibility. Br J Anaesth. 2015;115:531\u20139.","DOI":"10.1093\/bja\/aev225"},{"key":"3822_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s005400050002","volume":"14","author":"S Oku","year":"2000","unstructured":"Oku S, Mukaida K, Nosaka S, Sai Y, Maehara Y, Yuge O. Comparison of the in vitro caffeine-halothane contracture test with the Ca-induced Ca release rate test in patients suspected of having malignant hyperthermia susceptibility. J Anesth. 2000;14:6\u201313.","journal-title":"J Anesth"},{"key":"3822_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/0310057X1103900216","volume":"39","author":"M Kobayashi","year":"2011","unstructured":"Kobayashi M, Mukaida K, Migita T, Hamada H, Kawamoto M, Yuge O. Analysis of human cultured myotubes responses mediated by ryanodine receptor 1. Anaesth Intensive Care. 2011;39:252\u201361.","journal-title":"Anaesth Intensive Care"},{"key":"3822_CR12","doi-asserted-by":"publisher","first-page":"25722","DOI":"10.1074\/jbc.M302165200","volume":"278","author":"T Yang","year":"2003","unstructured":"Yang T, Ta TA, Pessah IN, Allen PD. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J Biol Chem. 2003;278:25722\u201330.","journal-title":"J Biol Chem"},{"key":"3822_CR13","doi-asserted-by":"crossref","unstructured":"Brinkmeier H, Kr\u00e4mer J, Kr\u00e4mer R, Iaizzo PA, Baur C, Lehmann-Horn F, R\u00fcdel R. Malignant hyperthermia causingGly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes. Br JAnaesth. 1999;83:855\u201361.","DOI":"10.1093\/bja\/83.6.855"},{"key":"3822_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1034\/j.1399-0004.2002.620206.x","volume":"62","author":"M Wehner","year":"2002","unstructured":"Wehner M, Rueffert H, Koenig F, Neuhaus J, Olthoff D. Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation. Clin Genet. 2002;62:135\u201346.","journal-title":"Clin Genet"},{"key":"3822_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0076-6879(88)57064-7","volume":"157","author":"M Endo","year":"1988","unstructured":"Endo M, Iino M. Measurement of Ca2+ release in skinned fibers from skeletal muscle. Methods Enzymol. 1988;157:12\u201326.","journal-title":"Methods Enzymol"},{"key":"3822_CR16","doi-asserted-by":"crossref","unstructured":"Miyoshi H, Otsuki S, Mukaida K, Kido K, Sumii A, Ikeda T, Noda Y, Yasuda T, Narasaki S, Kato T, Kamiya S,Horikawa YT, Tsutsumi YM. Eff ects of Remimazolam on Intracellular Calcium Dynamics in Myotubes Derived fromPatients with Malignant Hyperthermia and Functional Analysis of Type 1 Ryanodine Receptor Gene Variants. Genes\n(Basel). 2023;14.","DOI":"10.3390\/genes14112009"},{"key":"3822_CR17","doi-asserted-by":"crossref","unstructured":"Johnston JJ, Dirksen RT, Girard T, Hopkins PM, Kraeva N, Ognoon M, Radenbaugh KB, Riazi S, Robinson RL, SaddicIii LA, Sambuughin N, Saxena R, Shepherd S, Stowell K, Weber J, Yoo S, Rosenberg H, Biesecker LG. Updated variantcuration expert panel criteria and pathogenicity classifi cations for 251 variants for RYR1-related malignanthyperthermia susceptibility. Hum Mol Genet. 2022;31:4087\u201393.","DOI":"10.1093\/hmg\/ddac145"},{"key":"3822_CR18","doi-asserted-by":"crossref","unstructured":"Miyoshi H, Mukaida K, Otsuki S, Kido K, Sumii A, Ikeda T, Xia G, Noda Y, Ishii T, Kamiya S, Narasaki S, Niinai H,Tsutsumi YM. Genetic Panel Testing for Malignant Hyperthermia in Japan: Discovery of Novel Variants and ClinicalImplications. Genes (Basel). 2025;16:944.","DOI":"10.3390\/genes16080944"},{"key":"3822_CR19","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1074\/jbc.272.8.5256","volume":"272","author":"M Richter","year":"1997","unstructured":"Richter M, Schleithoff L, Deufel T, Lehmann-Horn F, Herrmann-Frank A. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J Biol Chem. 1997;272:5256\u201360.","journal-title":"J Biol Chem"},{"key":"3822_CR20","doi-asserted-by":"publisher","first-page":"C358","DOI":"10.1152\/ajpcell.1989.256.2.C358","volume":"256","author":"T Ohta","year":"1989","unstructured":"Ohta T, Endo M, Nakano T, Morohoshi Y, Wanikawa K, Ohga A. Ca-induced Ca release in malignant hyperthermia-susceptible pig skeletal muscle. Am J Physiol. 1989;256:C358\u201367.","journal-title":"Am J Physiol"},{"key":"3822_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/ALN.0b013e31818958e5","volume":"109","author":"RS Litman","year":"2008","unstructured":"Litman RS, Flood CD, Kaplan RF, Kim YL, Tobin JR. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry. Anesthesiology. 2008;109:825\u20139.","journal-title":"Anesthesiology"},{"key":"3822_CR22","unstructured":"Herrmann-Frank A, Richter M, Sarkszi S, Mohr U, Lehmann-Horn F. BB Biochiica et Biophysica Ata 4-chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim Biophys Acta. 1996"},{"key":"3822_CR23","doi-asserted-by":"crossref","unstructured":"van den Bersselaar LR, Schiemann AH, Yang CY, Voermans NC, Malagon I, Scheff er GJ, Bjorksten AR, Gillies R,Hellblom A, Kamsteeg EJ, Snoeck MMJ, Stowell KM. Pathogenicity assessment of seven RYR1 variants in patients withconfi rmed susceptibility to malignant hyperthermia in the Netherlands. Br J Anaesth. 2025;136:317\u2013325.","DOI":"10.1016\/j.bja.2024.11.043"},{"key":"3822_CR24","doi-asserted-by":"crossref","unstructured":"Otsuki S, Yasuda T, Mukaida K, Noda Y, Kanzaki R, Miyoshi H, Kondo T, Hamada H, Kawamoto M. Myotoxicity oflocal anesthetics is equivalent in individuals with and without predisposition to malignant hyperthermia. J Anesth.2018;32:616\u201323.","DOI":"10.1007\/s00540-018-2526-4"},{"key":"3822_CR25","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1093\/ajcn\/72.2.521S","volume":"72","author":"AD Rogol","year":"2000","unstructured":"Rogol AD, Clark PA, Roemmich JN. Growth and pubertal development in children and adolescents: effects of diet and physical activity. Am J Clin Nutr. 2000;72:S521\u20138.","journal-title":"Am J Clin Nutr"},{"key":"3822_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13539-011-0042-6","volume":"3","author":"CE Webber","year":"2012","unstructured":"Webber CE, Barr RD. Age- and gender-dependent values of skeletal muscle mass in healthy children and adolescents. J Cachexia Sarcopenia Muscle. 2012;3:25\u20139.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3822_CR27","doi-asserted-by":"crossref","unstructured":"Ward CW, Protasi F, Castillo D, Wang Y, Chen SR, Pessah IN, Allen PD, Schneider MF. Type 1 and type 3 ryanodinereceptors generate diff erent Ca(2+) release event activity in both intact and permeabilized myotubes. Biophys J.2001;81:3216\u201330.","DOI":"10.1016\/S0006-3495(01)75957-7"},{"key":"3822_CR28","doi-asserted-by":"publisher","first-page":"28727","DOI":"10.1074\/jbc.M303821200","volume":"278","author":"JD Fessenden","year":"2003","unstructured":"Fessenden JD, Perez CF, Goth S, Pessah IN, Allen PD. Identification of a key determinant of ryanodine receptor type 1 required for activation by 4-chloro-m-cresol. J Biol Chem. 2003;278:28727\u201335.","journal-title":"J Biol Chem"},{"key":"3822_CR29","doi-asserted-by":"crossref","unstructured":"Girard T, Cavagna D, Padovan E, Spagnoli G, Urwyler A, Zorzato F, Treves S. B-lymphocytes from malignanthyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators. JBiol Chem. 2001;276:48077\u201382.","DOI":"10.1074\/jbc.M107134200"},{"key":"3822_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0006-2952(96)00175-X","volume":"52","author":"A Herrmann-Frank","year":"1996","unstructured":"Herrmann-Frank A, Richter M, Lehmann-Horn F. 4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle. Biochem Pharmacol. 1996;52:149\u201355.","journal-title":"Biochem Pharmacol"},{"key":"3822_CR31","doi-asserted-by":"crossref","unstructured":"Baur CP, Bellon L, Felleiter P, Fiege M, Fricker R, Glahn K, Heff ron JJ, Herrmann-Frank A, Jurkat-Rott K, Klingler W,Lehane M, Ording H, Tegazzin V, Wappler F, Georgieff M, Lehmann-Horn F. A multicenter study of 4-chloro-m-cresolfor diagnosing malignant hyperthermia susceptibility. Anesth Analg. 2000;90:200\u20135.","DOI":"10.1097\/00000539-200001000-00040"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-026-03822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00540-026-03822-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-026-03822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:56:56Z","timestamp":1783331816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00540-026-03822-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":31,"alternative-id":["3822"],"URL":"https:\/\/doi.org\/10.1007\/s00540-026-03822-9","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"18 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}